StockData
Parabilis Medicines, Inc. logo

Parabilis Medicines, Inc. (PBLS) stock

PBLSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026
$28.47+0.22 (+0.78%)

Close on Nov 18, 2026Market cap $3.52BP/E –Yield –

Parabilis Medicines operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$50.89M–
Q2 FY2025Jun 30, 2025-$36.52M–

More Parabilis Medicines figures

See a number that looks wrong?